期刊文献+

新型超滤装置治疗难治性心力衰竭的有效性及安全性评价 被引量:26

Efficacy and safety of a novel ultrafiltration device for treating patients with refractory heart failure
原文传递
导出
摘要 目的探讨新型超滤装置治疗难治性心力衰竭患者的有效性和安全性。方法2009年11月至2014年5月新疆医科大学附属中医医院心脏重症监护病房共收治急性失代偿心力衰竭(ADHF)患者329例,按人选标准和排除标准进行筛查,最终共人选难治性心力衰竭患者52例。观察超滤治疗前后人选患者的体重、呼吸困难评分、血氧饱和度和左心室射血分数(LVEF)、肾功能、电解质、血气分析等指标和主要不良事件的发生情况。结果(1)超滤治疗的有效性观察结果:入选的52例患者中23例经肘正中静脉、29例经股静脉建立体外循环通路。超滤治疗持续8~22h,总超滤量为(4489±1548)ml(1944~7613ml)。超滤治疗后患者平均体重由(75.4±8.7)kg减低至(69.8±8.4)kg(P〈0.01),呼吸困难评分、血氧饱和度及LVEF均明显改善(P均〈0.01)。(2)超滤治疗的安全性观察结果:超滤治疗期间和超滤治疗后72h内未发生死亡、心肌梗死、心力衰竭加重等严重不良事件,治疗期间未发生有治疗意义的低血压事件。2例患者股静脉穿刺处渗血,未予特殊处理自愈,1例滤器内凝血,更换滤器后继续治疗。超滤治疗前后患者血电解质、肾功能、酸碱平衡、血红蛋白和血小板计数未见明显变化。结论新型超滤装置可有效缓解难治性心力衰竭患者的液体潴留和呼吸困难,未见严重不良事件发生,疗效安全、可靠。 Objective To evaluate the efficacy and safety of a new ultrafihration device for treating refractory heart failure patients. Methods A total of 52 patients (37 male, age 29 - 85 ( 33 ± 44) years) with refractory heart failure were treated using a new ultrafihration device (FQ-16). Body weight, dyspnea score, oxygen saturation (SatO2), left ventricular ejection fraction (LVEF), BUN, creatinine, electrolytes and blood gas analysis were assessed before and after the treatment. Hypotension event and other main adverse events were recorded. Results Uhrafiltration duration ranged between 8 -22 hours. Total ultrafiltration volume was (4 489±1 548) ml. Compared with baseline, patients' body weight decreased from (75.3 ±8.74) kg to ( 69. 8 ± 8.39 ) kg ( P 〈 0. 01 ), dyspnea score improved from 2.47± 1.55 to 12. 87±3.61 (P 〈 0. 01 ) and SatO~ increased from 91.0 ± 6. 01 to 96.4±2. 52 ( P 〈 0. 01 ) and LVEF increased from ( 30.0± 4. 1 ) % to ( 36. 0 ±4. 3 ) % ( P 〈 0. 01 ) after ultrafiltration. Blood creatinine, BUN, electrolytes and blood gas analysis values were similar at baseline and post ultrafiltration. No hypotension event and other main adverse events occurred during the ultrafihration treatment. Conclusions The novel uhrafihration device adequately relieved hypervolemia and dyspnea in patients with refractory heart failure and the treatment process is safe in this patient cohort.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2016年第6期489-493,共5页 Chinese Journal of Cardiology
关键词 心力衰竭 充血性 超滤 治疗结果 Heart failure, congestive Ultrafihration Treatment outcome
  • 相关文献

参考文献17

  • 1Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics- 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee [J]. Circulation, 2009, 119 (3) : 480-4-86. 被引量:1
  • 2Adams KF, Fonarow GC, Emerman CL, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE) [ J ]. Am Heart J, 2005,149 ( 2 ) : 209-216. 被引量:1
  • 3Felker GM, O'Connor CM, Braunwald E. Loop diuretics in acute decompensated heart failure: necessary? Evil? A necessary evil [J]. Circ Heart Fail, 2009, 2 ( 1 ) : 56-62. 被引量:1
  • 4Krum H, Cameron P. Diuretics in the treatment of heart failure: mainstay of therapy or potential hazard7 [ J]. J Card Fail, 2006, 12(5) :333-335. 被引量:1
  • 5Costanzo MR, Saltzberg M, O' Sullivan J, et al. Early ultrafiltration in patients with decompensated heart failure and diuretic resistance[ J]. J Am Coil Cardiol, 2005,46 (11 ) :2047- 2051. 被引量:1
  • 6Costanzo MR, Saltzberg MT, Jessup M, et al. Ultrafihration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD[J]. J Card Fail, 2010, 16(4) :277-284. 被引量:1
  • 7Marenzi G, Muratori M, Cosentino ER, et al. Continuous uhrafiltration for congestive heart failure: the CUORE trial [ J ]. J Card Fail, 2014,20( 1 ) :9-17. 被引量:1
  • 8无.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,35(12):1076-1095. 被引量:3677
  • 9Pang PS, Cleland JG, Teerlink JR, et al. A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach[J]. Eur Heart J, 2008,29(6) :816-824. 被引量:1
  • 10Bart BA, Boyle A, Bank AJ, et al. Uhrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial[J]. J Am Coil Cardiol, 2005, 46( 11 ) :2043-2046. 被引量:1

二级参考文献42

  • 1王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量:90
  • 2Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol, 1997, 80(11A) : 15L-25L 被引量:1
  • 3Braunwald E,Bristow MR Congestive heart failure: fifty years of progress. Circulation, 2000, 102(20 Suppl 4) : Ⅳ14-23. 被引量:1
  • 4Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) : developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation, 2005, 112 (12) :e154-235. 被引量:1
  • 5Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary ( update 2005 ):The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26(11): 1115-1140. 被引量:1
  • 6Arnold JM, Liu P, Demers C, et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006 : diagnosis and management. Can J Cardiol, 2006, 22 (1): 23-45. 被引量:1
  • 7Heart Failure Society of America. HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail, 2006, 12 ( 1 ) : e1-2. 被引量:1
  • 8Enright PL, Sherrill DL Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med, 1998, 158(5 pt 1) :1384-1387. 被引量:1
  • 9Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J, 1999, 14(2) : 270-274. 被引量:1
  • 10Maisel A. B-type natriuretic peptide levels: diagnostic and prognostic in congestive heart failure: what's next? Circulation, 2002, 105 (20):2328-2331. 被引量:1

共引文献3676

同被引文献148

引证文献26

二级引证文献173

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部